| Nov 15 |
Avenue Therapeutics GAAP EPS of -$1.92 misses by $0.92
|
| Nov 14 |
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
|
| Oct 9 |
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
|
| Sep 3 |
Avenue Therapeutics to Participate in Upcoming Investor Conferences
|
| Aug 26 |
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
|
| Aug 13 |
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
|
| Aug 9 |
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
|
